hVIVO plc (AIM:HVO)
4.670
-0.080 (-1.68%)
Nov 20, 2026, 4:22 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 32.08 million as of November 20, 2026. It is the 30,711th most valuable company in the world and the 671st biggest in the United Kingdom. Its market cap has decreased by 20.07% in one year.
Market Cap
32.08M
Enterprise Value
33.02M
Revenue
42.09M
Global Rank
Country Rank
#671 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 32.08M, an increase of 86.13%. That is a compound annual growth rate of 8.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 31.26M | -27.07% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.03B |
| GSK plc | 73.86B |
| Haleon | 30.36B |
| Smith & Nephew | 9.58B |
| Abingdon Health | 36.25M |
| BATM Advanced Communications | 35.71M |
| Arecor Therapeutics | 31.83M |
| Renalytix | 31.40M |